659 related articles for article (PubMed ID: 28385199)
1. Neuromyelitis Spectrum Disorders.
Weinshenker BG; Wingerchuk DM
Mayo Clin Proc; 2017 Apr; 92(4):663-679. PubMed ID: 28385199
[TBL] [Abstract][Full Text] [Related]
2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
3. [Clinical concept, etiology and pathology of neuromyelitis optica].
Kurosawa K; Fujihara K
Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
Alves Do Rego C; Collongues N
Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
[TBL] [Abstract][Full Text] [Related]
5. Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
You Y; Zhu L; Zhang T; Shen T; Fontes A; Yiannikas C; Parratt J; Barton J; Schulz A; Gupta V; Barnett MH; Fraser CL; Gillies M; Graham SL; Klistorner A
Ophthalmology; 2019 Jun; 126(6):801-810. PubMed ID: 30711604
[TBL] [Abstract][Full Text] [Related]
6. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
7. [Neuromyelitis optica].
Ferrán C; Pedemonte V; Turcatti E; González G
Medicina (B Aires); 2019; 79 Suppl 3():60-65. PubMed ID: 31603846
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
9. What You Need to Know About AQP4, MOG, and NMOSD.
Prasad S; Chen J
Semin Neurol; 2019 Dec; 39(6):718-731. PubMed ID: 31847043
[TBL] [Abstract][Full Text] [Related]
10. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
[TBL] [Abstract][Full Text] [Related]
11. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].
Aktas O; Kümpfel T
Nervenarzt; 2021 Apr; 92(4):307-316. PubMed ID: 33728474
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Kim SH; Kim HJ
Curr Opin Neurol; 2016 Jun; 29(3):372-80. PubMed ID: 27128108
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic criteria for neuromyelitisoptica spectrum disorders].
Belova AN; Bojko AN; Belova EM
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2 Pt 2):32-40. PubMed ID: 27070359
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorders.
Paul S; Mondal GP; Bhattacharyya R; Ghosh KC; Bhat IA
J Neurol Sci; 2021 Jan; 420():117225. PubMed ID: 33272591
[TBL] [Abstract][Full Text] [Related]
15. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
Takai Y; Misu T; Suzuki H; Takahashi T; Okada H; Tanaka S; Okita K; Sasou S; Watanabe M; Namatame C; Matsumoto Y; Ono H; Kaneko K; Nishiyama S; Kuroda H; Nakashima I; Lassmann H; Fujihara K; Itoyama Y; Aoki M
Brain; 2021 Sep; 144(8):2401-2415. PubMed ID: 33711152
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis Optica Spectrum Disorders.
Costello F
Continuum (Minneap Minn); 2022 Aug; 28(4):1131-1170. PubMed ID: 35938660
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
Caron-Cantin M; Cestari DM; Fortin E
Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Neuromyelitis Optica Spectrum Disorders.
Chan KH; Lee CY
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445343
[TBL] [Abstract][Full Text] [Related]
20. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]